Literature DB >> 10742647

Can we improve the diagnostic efficiency and predictive power of prodromal symptoms for schizophrenia?

P D McGorry1, D McKenzie, H J Jackson, F Waddell, C Curry.   

Abstract

Prodromal symptoms and other variables for a sample of 200 young people who had experienced a first-onset functional psychosis, were analyzed to examine their diagnostic efficiency and predictive power in relation to a diagnosis of schizophrenia. Two different techniques were utilized to generate optimal cut-off points for a number of prodromal symptoms, and optimal decision rules to maximize diagnostic efficiency. The product of the chance-corrected sensitivity and specificity, or the area under the QROC curve, was used to assess the predictive efficiency of a number of prodromal variables, DSM-III-R prodromal variables, pre-psychotic deterioration, pre-morbid functioning, and prodromal duration. The SPAN technique generated a decision rule that performed equivalently to the single variable 'duration of prodrome'. Implications of these results for future research are discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10742647     DOI: 10.1016/s0920-9964(99)00125-5

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  10 in total

Review 1.  Assessment of adolescents at risk for psychosis.

Authors:  Karin Borgmann-Winter; Monica E Calkins; Kathryn Kniele; Raquel E Gur
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

Review 2.  A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment.

Authors:  Opal Ousley; Kimberly Rockers; Mary Lynn Dell; Karlene Coleman; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

3.  Gray matter loss in young relatives at risk for schizophrenia: relation with prodromal psychopathology.

Authors:  Tejas S Bhojraj; John A Sweeney; Konasale M Prasad; Shaun M Eack; Alan N Francis; Jean M Miewald; Debra M Montrose; Matcheri S Keshavan
Journal:  Neuroimage       Date:  2010-05-02       Impact factor: 6.556

4.  Predicting future depression in adolescents using the Short Mood and Feelings Questionnaire: a two-nation study.

Authors:  Dean P McKenzie; John W Toumbourou; Andrew B Forbes; Andrew J Mackinnon; Barbara J McMorris; Richard F Catalano; George C Patton
Journal:  J Affect Disord       Date:  2011-06-13       Impact factor: 4.839

5.  Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis.

Authors:  Arsime Demjaha; Lucia Valmaggia; Daniel Stahl; Majella Byrne; Philip McGuire
Journal:  Schizophr Bull       Date:  2010-08-12       Impact factor: 9.306

6.  Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome.

Authors:  Christoph U Correll; Julie B Penzner; Anne M Frederickson; Jessica J Richter; Andrea M Auther; Christopher W Smith; John M Kane; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2007-05-02       Impact factor: 9.306

Review 7.  Kraepelin and psychotic prodromal conditions.

Authors:  Joachim Klosterkötter; Frauke Schultze-Lutter; Stephan Ruhrmann
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

8.  Capturing adolescents in need of psychiatric care with psychopathological symptoms: A population-based cohort study.

Authors:  Anat Rotstein; Judy Goldenberg; Suzan Fund; Stephen Z Levine; Abraham Reichenberg
Journal:  Eur Psychiatry       Date:  2021-11-29       Impact factor: 5.361

9.  Early intervention in schizophrenia.

Authors:  Parmanand Kulhara; Anindya Banerjee; Alakananda Dutt
Journal:  Indian J Psychiatry       Date:  2008-04       Impact factor: 1.759

10.  Association of Primary Care Consultation Patterns With Early Signs and Symptoms of Psychosis.

Authors:  Sarah A Sullivan; William Hamilton; Kate Tilling; Theresa Redaniel; Paul Moran; Glyn Lewis
Journal:  JAMA Netw Open       Date:  2018-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.